J
jwswaco
This info was in the QAS email newsletter. Sounds interesting!
New "Polypill" Could Reduce Heart Attacks and Strokes
A new study published in the British Medical Journal reveals that the ?Polypill? could largely prevent stroke and heart disease among patients ages 55 and older with a history of cardiovascular problems. The four-part pill contains aspirin, folic acid and other drugs and could cut heart attacks and strokes by more than 80 percent if taken daily. Researchers looked at data from 750 trials involving 400,000 people.
They came up with a pill containing six active components -- aspirin, folic acid, a cholesterol-lowering drug and three drugs to lower blood pressure at half the normal dose. They concluded their Polypill could prevent 88 percent of heart attacks and 80 percent of strokes. Each part of the pill would reduce one of four cardiovascular risk factors, and about one in three people would directly benefit, with each on average gaining 11-12 years of life without heart attack or stroke. The researchers said the pill could be taken without the need for a medical examination or any individual measurement of risk factors. Future trials of the Polypill will take several years to determine efficacy and safety.
New "Polypill" Could Reduce Heart Attacks and Strokes
A new study published in the British Medical Journal reveals that the ?Polypill? could largely prevent stroke and heart disease among patients ages 55 and older with a history of cardiovascular problems. The four-part pill contains aspirin, folic acid and other drugs and could cut heart attacks and strokes by more than 80 percent if taken daily. Researchers looked at data from 750 trials involving 400,000 people.
They came up with a pill containing six active components -- aspirin, folic acid, a cholesterol-lowering drug and three drugs to lower blood pressure at half the normal dose. They concluded their Polypill could prevent 88 percent of heart attacks and 80 percent of strokes. Each part of the pill would reduce one of four cardiovascular risk factors, and about one in three people would directly benefit, with each on average gaining 11-12 years of life without heart attack or stroke. The researchers said the pill could be taken without the need for a medical examination or any individual measurement of risk factors. Future trials of the Polypill will take several years to determine efficacy and safety.